Bayer
€44.94Change from previous close: −1.01%Absolute change: −€0.46
At a glance
- Revenue growth
- −2.21%
- 2025 vs 2024
- Net margin
- -7.9%
- 2024: -5.5%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5,930 | 7,368 | 5,117 | 7,093 | 5,089 | 4,903 | 8,207 | 7,917 | 8,134 | 9,089 |
| Depreciation and amortization | 4,088 | 4,049 | 3,909 | 3,949 | 3,740 | 3,444 | 4,214 | 2,888 | 2,120 | 2,358 |
| Capital expenditure | -2,487 | -2,778 | -2,751 | -2,949 | -2,611 | -2,418 | -2,650 | -2,593 | -2,366 | -2,578 |
| Investing cash flow | -1,270 | 164 | -3,517 | -2,381 | 855 | -4,073 | -671 | -34,152 | -432 | -8,729 |
| Financing cash flow | -3,884 | -7,178 | -679 | -4,220 | -5,645 | 423 | -8,389 | 23,432 | -1,881 | -350 |
| Dividends paid | -108 | -108 | -2,358 | -1,985 | -1,993 | -2,751 | -2,611 | -2,402 | -2,233 | -2,068 |
| Share repurchases | -14.0 | -16.0 | -24.0 | -25.0 | — | — | — | — | — | — |
| Debt issued | 6,282 | 5,815 | 16,284 | 6,631 | 6,592 | 10,891 | 7,464 | 65,090 | 10,369 | 15,190 |
| Debt repaid | -8,327 | -10,833 | -13,031 | -7,605 | -9,044 | -6,424 | -11,760 | -47,271 | -12,848 | -15,920 |
| Effect of exchange rates | -291 | -10.0 | -185 | 112 | 35.0 | -240 | 6.0 | -581 | -139 | 27.0 |
| Net change in cash | 480 | 284 | 736 | 607 | 373 | 1,006 | -867 | -3,383 | 5,682 | 40.0 |
| Free cash flow | 3,443 | 4,590 | 2,366 | 4,144 | 2,478 | — | — | — | — | — |
| Levered free cash flow | 8,533 | 3,684 | 739 | 5,847 | 1,224 | 14,918 | 5,792 | 4,798 | 4,387 | 1,799 |